J. D. Del Rosso

发表

JAK inhibitors in the treatment of atopic dermatitis

B. Glick, Ben Witkoff, Christopher M. Logas, 2022, Dermatological Reviews.

J. D. Del Rosso, J. Zeichner, 2016, Dermatologic clinics.

Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.

J. D. Del Rosso, 2012, The Journal of clinical and aesthetic dermatology.

Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne.

J. D. Del Rosso, J. Bikowski, 2008, Journal of drugs in dermatology : JDD.

Current regimens and guideline implications for the treatment of actinic keratosis: proceedings of a clinical roundtable at the 2011 Winter Clinical Dermatology Conference.

J. D. Del Rosso, 2011, Cutis.

Healthcare utilization and costs of patients with rosacea in an insured population.

J. Stephenson, G. Lenhart, J. D. Del Rosso, 2008, Journal of drugs in dermatology : JDD.

Applying the phenotype approach for rosacea to practice and research

R. Gallo, J. Tan, J. D. Del Rosso, 2018, The British journal of dermatology.

Activity of Dapsone versus Community and Hospital Pathogens from the CANWARD Study.

G. Zhanel, J. D. Del Rosso, 2016, ˜The œJournal of clinical and aesthetic dermatology.

Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report.

J. Leyden, G. Webster, J. D. Del Rosso, 2009, Dermatologic clinics.

Revisiting the Beneficial Effects of Estrogen on the Skin: A Comprehensive Review of the Literature and a Look to the Future

Z. Draelos, J. D. Del Rosso, J. Zeichner, 2018, SKIN The Journal of Cutaneous Medicine.

Betamethasone Valerate in Foam Vehicle Is Effective with Both Daily and Twice a Day Dosing: A Single-Blind, Open-Label Study in the Treatment of Scalp Psoriasis

S. Feldman, A. Fleischer, J. Weiss, 2001, Journal of cutaneous medicine and surgery.

Treatment Satisfaction, Product Perception, and Quality of Life in Plaque Psoriasis Patients Using Betamethasone Dipropionate Spray 0.05.

J. Fowler, R. I. Pakunlu, J. D. Del Rosso, 2017, The Journal of clinical and aesthetic dermatology.

Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis.

J. D. Del Rosso, S. Bhambri, 2009, The Journal of clinical and aesthetic dermatology.

Sarecycline: A Review of Preclinical and Clinical Evidence

A. Grada, A. Moore, Jodi L. Johnson, 2020, Clinical, cosmetic and investigational dermatology.

Atypical mycobacterial cutaneous infections.

J. D. Del Rosso, S. Bhambri, A. Bhambri, 2009, Dermatologic clinics.

Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.

Grace K. Kim, R. Winkelmann, J. D. Del Rosso, 2013, The Journal of clinical and aesthetic dermatology.

Shortcomings in rosacea diagnosis and classification

J. Leyden, M. Schaller, M. Steinhoff, 2017, The British journal of dermatology.

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea.

D. Thiboutot, R. Gallo, L. Eichenfield, 2014, Cutis.

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care.

D. Thiboutot, R. Gallo, L. Eichenfield, 2013, Cutis.

Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema.

J. D. Del Rosso, 2012, The Journal of clinical and aesthetic dermatology.

The ORCA (Oracea for rosacea: a community-based assessment) trial: a large-scale, phase 4 trial in papulopustular rosacea.

J. D. Del Rosso, 2010, Cutis.

Gaps and recommendations for clinical management of truncal acne from the Personalising Acne: Consensus of Experts panel

B. Dréno, S. Beissert, Jerry Tan, 2021, JAAD international.

Identifying gaps and providing recommendations to address shortcomings in the investigation of acne sequelae by the Personalising Acne: Consensus of Experts panel

B. Dréno, S. Beissert, Jerry Tan, 2021, JAAD international.

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies.

D. Thiboutot, R. Gallo, L. Eichenfield, 2014, Cutis.

An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea.

D. Thiboutot, R. Gallo, G. Webster, 2013, Cutis.

Optimizing topical therapies for treating psoriasis: a consensus conference.

B. Elewski, M. Lebwohl, S. Feldman, 2010, Cutis.

Rethinking the Journal Impact Factor and Publishing in the Digital Age.

B. Berman, J. D. Del Rosso, M. Nestor, 2020, The Journal of clinical and aesthetic dermatology.

Atopic dermatitis and the stratum corneum: part 3: the immune system in atopic dermatitis.

J. D. Del Rosso, J. Levin, Sheila Fallon Friedlander, 2013, The Journal of clinical and aesthetic dermatology.

Topical antibiotics: therapeutic value or ecologic mischief?

Grace K. Kim, J. D. Del Rosso, 2009, Dermatologic therapy.

The new and old: Atopic dermatitis biologics

B. Glick, Christopher M. Logas, J. D. Del Rosso, 2022, Dermatological Reviews.

The sequence of inflammation, relevant biomarkers, and the pathogenesis of acne vulgaris: what does recent research show and what does it mean to the clinician?

L. Kircik, J. D. Del Rosso, 2013, Journal of drugs in dermatology : JDD.

Evidence‐based recommendations for the management of acne fulminans and its variants

J. Leyden, M. Levin, D. Thiboutot, 2017, Journal of the American Academy of Dermatology.

Evolving perspectives on the etiology and pathogenesis of acne vulgaris.

J. Weiss, L. Eichenfield, L. Kircik, 2015, Journal of drugs in dermatology : JDD.

Psychosocial judgements and perceptions of adolescents with acne vulgaris: A blinded, controlled comparison of adult and peer evaluations

J. D. Del Rosso, E. Ritvo, Mark A Stillman, 2011, BioPsychoSocial medicine.

Emerging topical antimicrobial options for mild-to-moderate acne: a review of the clinical evidence.

J. D. Del Rosso, 2008, Journal of drugs in dermatology : JDD.

Coal tar 2% foam in combination with a superpotent corticosteroid foam for plaque psoriasis: case report and clinical implications.

Amylynne J Frankel, J. D. Del Rosso, J. Zeichner, 2010, The Journal of clinical and aesthetic dermatology.

Use of Topical Tazarotene for the Treatment of Acne Vulgaris in Pregnancy: A Literature Review.

Jashin J. Wu, G. Han, J. D. Del Rosso, 2020, The Journal of clinical and aesthetic dermatology.

Halobetasol 0.01%/Tazarotene 0.045% Fixed-combination Lotion in the Treatment of Plaque Psoriasis: Sensitization and Irritation Potential.

L. Kircik, J. D. Del Rosso, Tina Lin, 2019, The Journal of clinical and aesthetic dermatology.

ROLE OF ADRENOCEPTORS IN PFE AND THE ADRENOCEPTOR AGONIST MECHANISM OF ACTION

E. Tanghetti, J. D. Del Rosso, 2021 .

Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel.

R. Gallo, K. Yamasaki, J. Harper, 2013, Journal of the American Academy of Dermatology.

The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review

M. Schaller, G. Micali, T. Dirschka, 2021, Acta dermato-venereologica.

Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel†

M. Schaller, A. Bewley, M. Mannis, 2019, British Journal of Dermatology.

Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 4: a status report on physical modalities and devices.

D. Thiboutot, R. Gallo, L. Eichenfield, 2014, Cutis.

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents.

D. Thiboutot, R. Gallo, L. Eichenfield, 2013, Cutis.

Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).

D. Thiboutot, R. Gallo, G. Webster, 2019, The Journal of clinical and aesthetic dermatology.

The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey.

E. Tanghetti, H. Baldwin, I. Ferrusi, 2017, The Journal of clinical and aesthetic dermatology.

Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea.

J. D. Del Rosso, 2017, The Journal of clinical and aesthetic dermatology.

Management of cutaneous rosacea: emphasis on new medical therapies

J. D. Del Rosso, James Q. Del Rosso, 2014, Expert opinion on pharmacotherapy.

Management of facial erythema of rosacea: what is the role of topical α-adrenergic receptor agonist therapy?

J. D. Del Rosso, 2013, Journal of the American Academy of Dermatology.

Optimal management of papulopustular rosacea: rationale for combination therapy.

J. D. Del Rosso, N. Bhatia, 2012, Journal of drugs in dermatology : JDD.

Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea.

A. Menter, M. Jarratt, J. D. Del Rosso, 2010, Journal of drugs in dermatology : JDD.

A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.

A. Fleischer, D. Thiboutot, J. D. Del Rosso, 2009, Journal of drugs in dermatology : JDD.

Oral antibiotic drug interactions of clinical significance to dermatologists.

J. D. Del Rosso, 2009, Dermatologic clinics.

American Acne & Rosacea Society rosacea medical management guidelines.

G. Webster, H. Baldwin, J. D. Del Rosso, 2008, Journal of drugs in dermatology : JDD.

Comprehensive medical management of rosacea: an interim study report and literature review.

J. D. Del Rosso, E. Baum, 2008, The Journal of clinical and aesthetic dermatology.

Status report on antibiotic resistance: implications for the dermatologist.

J. Leyden, J. D. Del Rosso, 2007, Dermatologic clinics.

Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.

J. Leyden, G. Webster, J. D. Del Rosso, 2007, Cutis.

Pathogenesis of acne vulgaris: recent advances.

J. D. Del Rosso, S. Bhambri, A. Bhambri, 2009, Journal of drugs in dermatology : JDD.

Cutaneous rosacea: a thorough overview of pathogenesis, clinical presentations, and current recommendations on management

J. D. Del Rosso, 2016, Vestnik dermatologii i venerologii.

Topical corticosteroid application and the structural and functional integrity of the epidermal barrier.

J. D. Del Rosso, K. Cash, 2013, The Journal of clinical and aesthetic dermatology.

Patient Awareness of Antimicrobial Resistance and Antibiotic Use in Acne Vulgaris.

T. Rosen, J. D. Del Rosso, M. Rueda, 2019, The Journal of clinical and aesthetic dermatology.

Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin.

D. Thiboutot, R. Gallo, L. Kircik, 2012, Journal of drugs in dermatology : JDD.

Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application.

J. D. Del Rosso, N. Bhatia, 2011, Cutis.

Anti-inflammatory activity of tetracyclines.

G. Webster, J. D. Del Rosso, 2007, Dermatologic clinics.

A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40 mg modified-release capsules versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.

M. Schaller, M. Gooderham, L. Kemény, 2020, Journal of the American Academy of Dermatology.

Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea.

J. Schlessinger, J. D. Del Rosso, P. Werschler, 2008, Journal of drugs in dermatology : JDD.

Medical treatment of rosacea with emphasis on topical therapies.

J. D. Del Rosso, 2004, Expert opinion on pharmacotherapy.

Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

J. D. Del Rosso, 2017, The Journal of clinical and aesthetic dermatology.

Acne severity grading: determining essential clinical components and features using a Delphi consensus.

M. Chren, J. Leyden, Jerry Tan, 2012, Journal of the American Academy of Dermatology.

The Clinical Relevance of Antibiotic Resistance: Thirteen Principles That Every Dermatologist Needs to Consider When Prescribing Antibiotic Therapy.

J. D. Del Rosso, J. Zeichner, 2016, Dermatologic clinics.

Update on rosacea pathogenesis and correlation with medical therapeutic agents.

J. D. Del Rosso, 2006, Cutis.

Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea.

I. Stuart, L. Kircik, L. Stein Gold, 2020, The Journal of clinical and aesthetic dermatology.

Minocycline 1.5% Foam for the Topical Treatment of Moderate-to-Severe Papulopustular Rosacea: Results of Two Phase 3, Randomized, Clinical Trials.

I. Stuart, L. Kircik, J. D. Del Rosso, 2020, Journal of the American Academy of Dermatology.

Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives.

J. Leyden, J. D. Del Rosso, 2011, The Journal of clinical and aesthetic dermatology.

Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.

J. D. Del Rosso, 2010, Cutis.

Anti-inflamatory dose doxycycline in the treatment of rosacea.

J. D. Del Rosso, 2009, Journal of drugs in dermatology : JDD.

Systemic therapy for rosacea: focus on oral antibiotic therapy and safety.

J. D. Del Rosso, 2000, Cutis.

Medical treatment of rosacea with emphasis on topical therapies

J. D. Del Rosso, 2004 .

A status report on the medical management of rosacea: focus on topical therapies.

J. D. Del Rosso, 2002, Cutis.

Itch: an under‐recognized problem in psoriasis

B. Elewski, M. Lebwohl, G. Yosipovitch, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

MONOCLONAL ANTIBODY THERAPIES for Atopic Dermatitis: Where Are We Now in the Spectrum of Disease Management?

J. D. Del Rosso, 2019, The Journal of clinical and aesthetic dermatology.

The Personalised Acne Care Pathway—Recommendations to guide longitudinal management from the Personalising Acne: Consensus of Experts

B. Dréno, S. Beissert, Jerry Tan, 2021, JAAD international.

An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents

Aditya K. Gupta, J. D. Del Rosso, 2000, International journal of dermatology.

Reduced blood-brain barrier penetration of acne vulgaris antibiotic sarecycline compared to minocycline corresponds with lower lipophilicity

A. Grada, A. Moore, J. Harper, 2022, Frontiers in Medicine.

Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 3: oral therapies.

E. Graber, D. Thiboutot, L. Eichenfield, 2015, Cutis.

Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier?

D. Thiboutot, J. D. Del Rosso, 2013, The Journal of clinical and aesthetic dermatology.

Optimizing use of oral antibiotics in acne vulgaris.

Grace K. Kim, J. D. Del Rosso, 2009, Dermatologic clinics.

Clinical Manifestations and Management Considerations of Psoriasis Affecting The Nail Unit

M. Lebwohl, J. D. Del Rosso, J. Rosso, 2018, SKIN The Journal of Cutaneous Medicine.

Skin cancer in asians: part 1: nonmelanoma skin cancer.

Grace K. Kim, Susun Bellew, J. D. Del Rosso, 2009, The Journal of clinical and aesthetic dermatology.

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.

M. Lebwohl, Z. Draelos, M. Gooderham, 2022, JAMA.

Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations

J. Dover, M. Longaker, J. Leyden, 2017, JAMA dermatology.

Systemic retinoid therapy: a status report on optimal use and safety of long-term therapy.

Alpesh Desai, Francisca Kartono, J. D. Del Rosso, 2007, Dermatologic clinics.

Calciphylaxis: a review.

J. D. Del Rosso, A. Bhambri, James Q. Del Rosso, 2008, The Journal of clinical and aesthetic dermatology.

Dermatofibrosarcoma protuberans: a case report and review of the literature.

Avani Desai, J. D. Del Rosso, S. Bhambri, 2008, The Journal of clinical and aesthetic dermatology.

Multivesicular Emulsion Ceramide-containing Moisturizers: An Evaluation of Their Role in the Management of Common Skin Disorders.

J. D. Del Rosso, J. Zeichner, 2016, ˜The œJournal of clinical and aesthetic dermatology.

Use of Polypodium leucotomas Extract in Clinical Practice: A Primer for the Clinician.

J. D. Del Rosso, 2016, The Journal of clinical and aesthetic dermatology.

Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology

E. Tanghetti, L. Stein Gold, J. D. Del Rosso, 2019, The Journal of dermatological treatment.

Ceramide- and Keratolytic-containing Body Cleanser and Cream Application in Patients with Psoriasis: Outcomes from a Consumer Usage Study.

J. D. Del Rosso, 2019, The Journal of clinical and aesthetic dermatology.

The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin.

J. D. Del Rosso, J. Levin, 2011, The Journal of clinical and aesthetic dermatology.

Impact of order of application of moisturizers on percutaneous absorption kinetics: evaluation of sequential application of moisturizer lotions and azelaic acid gel 15% using a human skin model.

S. Raney, P. Lehman, J. D. Del Rosso, 2009, Cutis.

The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study.

J. D. Del Rosso, 2009, Cutis.

Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.

Z. Draelos, E. Tanghetti, J. D. Del Rosso, 2006, Cutis.

The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.

J. D. Del Rosso, 2014, The Journal of clinical and aesthetic dermatology.

Wound care in the dermatology office: where are we in 2011?

J. D. Del Rosso, 2011, Journal of the American Academy of Dermatology.

Topical Corticosteroid Therapy for Psoriasis-A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification.

J. D. Del Rosso, 2020, The Journal of clinical and aesthetic dermatology.

Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne

S. Orlow, K. Vaux, D. Thiboutot, 2013, Pediatrics.

Prevalence of superficial fungal infections among sports‐active individuals: results from the Achilles survey, a review of the literature

R. Nowicki, J. D. Del Rosso, K. De Boulle, 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

The use of intermittent itraconazole therapy for superficial mycotic infections: a review and update on the 'one week' approach.

A. Gupta, J. D. Del Rosso, 1999, International journal of dermatology.

Antifungal agents for onychomycosis: new treatment strategies to improve safety.

D. Coronado, S. Chanda, J. D. Del Rosso, 2016, Dermatology online journal.

Tinea capitis in infants: recognition, evaluation, and management suggestions.

J. D. Del Rosso, B. Michaels, 2012, The Journal of clinical and aesthetic dermatology.

Onychomycosis of Toenails and Post-hoc Analyses with Efinaconazole 10% Solution Once-daily Treatment: Impact of Disease Severity and Other Concomitant Associated Factors on Selection of Therapy and Therapeutic Outcomes.

J. D. Del Rosso, 2016, The Journal of clinical and aesthetic dermatology.

Itraconazole in the treatment of superficial cutaneous and mucosal Candida infections.

A. Gupta, J. D. Del Rosso, S. Zellis, 1998, The Journal of the American Osteopathic Association.

Management of tinea capitis. A status report.

A. Gupta, J. D. Del Rosso, 1999, Postgraduate medicine.

Onychomycosis in children: prevalence and management.

A. Gupta, J. D. Del Rosso, P. Chang, 1998, Pediatric dermatology.

Adult seborrheic dermatitis: a status report on practical topical management.

J. D. Del Rosso, 2011, The Journal of clinical and aesthetic dermatology.

Hepatic Safety of Itraconazole

Aditya K. Gupta, J. D. Del Rosso, R. Baran, 2002, Journal of cutaneous medicine and surgery.

Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.

L. Kircik, J. D. Del Rosso, 2013, Journal of drugs in dermatology : JDD.

A Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses.

L. Kircik, J. D. Del Rosso, 2012, The Journal of clinical and aesthetic dermatology.

Demodex dermatitis: a retrospective analysis of clinical diagnosis and successful treatment with topical crotamiton.

J. D. Del Rosso, J. Bikowski, 2009, The Journal of clinical and aesthetic dermatology.

Perspectives on seborrheic dermatitis: looking back to move ahead.

J. D. Del Rosso, 2009, Clinics in dermatology.

The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.

L. Kircik, J. D. Del Rosso, 2012, Journal of drugs in dermatology : JDD.

Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance.

Grace K. Kim, J. D. Del Rosso, 2010, The Journal of clinical and aesthetic dermatology.

Mycetoma clinically masquerading as squamous cell carcinoma: case report and literature review.

J. D. Del Rosso, N. Mobini, S. Momin, 2009, The Journal of clinical and aesthetic dermatology.

Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations.

J. D. Del Rosso, 2004, Cutis.

Use of oral isotretinoin in the management of rosacea.

James Q Del Rosso, Hyunhee Park, J. D. Del Rosso, 2011, The Journal of clinical and aesthetic dermatology.

Corticosteroids: options in the era of steroid-sparing therapy.

S. Friedlander, J. D. Del Rosso, 2005, Journal of the American Academy of Dermatology.

Efinaconazole 10% solution: a new topical treatment for onychomycosis: contact sensitization and skin irritation potential.

J. D. Del Rosso, Kathleen J. Smith, B. Reece, 2013, The Journal of clinical and aesthetic dermatology.

Modern methods to treat superficial fungal disease.

Z. Draelos, W. Joseph, J. Jorizzo, 2007, Cutis.

Application of Nail Polish During Topical Management of Onychomycosis: Are Data Available to Guide the Clinician About What to Tell Their Patients?

J. D. Del Rosso, 2016, The Journal of clinical and aesthetic dermatology.

Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits

M. Lebwohl, E. Tanghetti, L. Stein Gold, 2021, Dermatology and Therapy.

Considerations in the Management of Actinic Keratoses: The Importance of Adherence and Persistence to Therapy

D. Rigel, Justin W Marson, J. D. Del Rosso, 2021 .

Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy

J. D. Del Rosso, 1996, The Journal of the American Osteopathic Association.

Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis

J. D. Del Rosso, 1997, The Journal of the American Osteopathic Association.

Azelaic Acid Topical Formulations: Differentiation of 15% Gel and 15% Foam.

J. D. Del Rosso, 2017, The Journal of clinical and aesthetic dermatology.

From the Test Tube to the Treatment Room: Fundamentals of Boron-containing Compounds and their Relevance to Dermatology.

J. Plattner, J. D. Del Rosso, 2014, The Journal of clinical and aesthetic dermatology.

Topical tazarotene in acne vulgaris: treatment approaches.

E. Tanghetti, J. D. Del Rosso, L. Zane, 2004, Cutis.

Current modalities and new advances in the treatment of basal cell carcinoma

R. Ceilley, J. D. Del Rosso, 2006, International journal of dermatology.

Comparative efficacy and safety results of topical hemostatic powder and sterile compressed foam sponge in second intention healing following Mohs micrographic surgery.

L. Kircik, J. D. Del Rosso, 2010, Journal of drugs in dermatology : JDD.

Sarecycline Demonstrated Reduced Activity Compared to Minocycline against Microbial Species Representing Human Gastrointestinal Microbiota

A. Grada, M. Ghannoum, S. Tyring, 2022, Antibiotics.

Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing,

J. Leyden, D. Thiboutot, R. Gallo, 2016, The Journal of clinical and aesthetic dermatology.

Management of Truncal Acne With Oral Sarecycline: Pooled Results from Two Phase-3 Clinical Trials.

A. Grada, E. Graber, H. Baldwin, 2021, Journal of drugs in dermatology : JDD.

Truncal Acne: A Neglected Entity

C. Lynde, A. Alexis, E. Tanghetti, 2019, Journal of drugs in dermatology : JDD.

Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.

M. Gooderham, Jerry Tan, D. Thiboutot, 2019, Journal of the American Academy of Dermatology.

Management of Truncal Acne Vulgaris with Topical Dapsone 7.5% Gel.

L. Kircik, E. Tanghetti, J. D. Del Rosso, 2018, The Journal of clinical and aesthetic dermatology.

The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris.

L. Kircik, L. Hoffman, J. D. Del Rosso, 2017, Journal of drugs in dermatology : JDD.

The effect of benzoyl peroxide 9.8% emollient foam on reduction of Propionibacterium acnes on the back using a short contact therapy approach.

J. Leyden, J. D. Del Rosso, 2012, Journal of drugs in dermatology : JDD.

A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance.

J. D. Del Rosso, N. Bhatia, J. Bikowski, 2007, Journal of drugs in dermatology : JDD.

Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy.

J. D. Del Rosso, 2007, Journal of drugs in dermatology : JDD.

Sarecycline treatment for acne vulgaris: Rationale for weight‐based dosing and limited impact of food intake on clinical efficacy

A. Grada, E. Graber, A. Moore, 2021, Dermatologic therapy.

Tazarotene 0.045% Lotion for Moderate-to-Severe Acne Patients: Pooled Phase 3 Analysis by Age and Sex.

E. Tanghetti, J. D. Del Rosso, L. Green, 2021, Journal of drugs in dermatology : JDD.

Formulation and Profile of FMX101 4% Minocycline Topical Foam for the Treatment of Acne Vulgaris.

I. Stuart, A. London, J. Weiss, 2020, The Journal of clinical and aesthetic dermatology.

Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation.

J. D. Del Rosso, 2015, The Journal of clinical and aesthetic dermatology.

A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines.

J. D. Del Rosso, 2004, Cutis.

Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.

J. Leyden, Z. Draelos, P. Grimes, 2010, Journal of Drugs in Dermatology.

Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 2: topical therapies.

E. Graber, D. Thiboutot, L. Eichenfield, 2015, Cutis.

Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series

A. Alexis, J. D. Del Rosso, E. Lain, 2022, Dermatology and Therapy.

Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach.

G. Goldenberg, L. Kircik, J. D. Del Rosso, 2014, The Journal of clinical and aesthetic dermatology.

Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications.

A. Layton, L. Kircik, J. Schauber, 2016, Journal of drugs in dermatology : JDD.

Polypodium leucotomos extract: a status report on clinical efficacy and safety.

D. Rigel, R. Winkelmann, J. D. Del Rosso, 2015, Journal of drugs in dermatology : JDD.

Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids.

L. Kircik, J. D. Del Rosso, 2011, The Journal of clinical and aesthetic dermatology.

Evaluating Clinical Use of a Ceramide-dominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis.

L. Kircik, J. D. Del Rosso, Daniela Aversa, 2011, The Journal of clinical and aesthetic dermatology.

Oral cephalosporin antibiotics: an overview of clinical pharmacology and dermatologic applications.

J. D. Del Rosso, 2003, Cutis.

Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study

L. Eichenfield, L. Kircik, J. Harper, 2019, The British journal of dermatology.

A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris.

J. D. Del Rosso, Nicholas Schmidt, 2010, Cutis.

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review

Z. Fedorowicz, A. Layton, E. V. van Zuuren, 2017, American Journal of Clinical Dermatology.

Androgens, Androgen Receptors, and the Skin: From the Laboratory to the Clinic With Emphasis on Clinical and Therapeutic Implications.

D. Thiboutot, L. Kircik, L. Stein Gold, 2020, Journal of drugs in dermatology : JDD.

Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience.

Grace K. Kim, J. D. Del Rosso, 2012, The Journal of clinical and aesthetic dermatology.

Acute generalized exanthematous pustulosis: an enigmatic drug-induced reaction.

J. D. Del Rosso, N. Mobini, S. Momin, 2009, Cutis.

A Closer Look at Seborrheic Keratoses: Patient Perspectives, Clinical Relevance, Medical Necessity, and Implications for Management.

J. D. Del Rosso, 2017, The Journal of clinical and aesthetic dermatology.

Clindamycin phosphate-tretinoin combination gel revisited: status report on a specific formulation used for acne treatment.

J. D. Del Rosso, 2017, Cutis.

Skin cancer in asians: part 2: melanoma.

Grace K. Kim, Susun Bellew, J. D. Del Rosso, 2009, The Journal of clinical and aesthetic dermatology.

Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses.

H. Sofen, J. D. Del Rosso, S. Levy, 2009, ˜The œJournal of clinical and aesthetic dermatology.

Solitary sclerotic fibroma.

J. D. Del Rosso, A. Bhambri, 2009, The Journal of clinical and aesthetic dermatology.

Trolamine-containing topical emulsion: clinical applications in dermatology.

J. D. Del Rosso, J. Bikowski, 2008, Cutis.

Efficacy, safety, and subject satisfaction of a specified skin care regimen to cleanse, medicate, moisturize, and protect the skin of patients under treatment for acne vulgaris.

M. Gold, W. Winkelman, J. D. Del Rosso, 2015, The Journal of clinical and aesthetic dermatology.

When Acne is Not Acne.

N. Silverberg, J. D. Del Rosso, J. Zeichner, 2016, Dermatologic clinics.

The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions.

J. Leyden, J. D. Del Rosso, E. Baum, 2014, The Journal of clinical and aesthetic dermatology.

Face to face with oral isotretinoin: a closer look at the spectrum of therapeutic outcomes and why some patients need repeated courses.

J. D. Del Rosso, 2012, The Journal of clinical and aesthetic dermatology.

Current approach to acne management: a community-based analysis.

A. Mancini, G. Webster, J. Keri, 2009, Cutis.

Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices.

N. Zeitouni, D. Siegel, R. Ceilley, 2021, The Journal of clinical and aesthetic dermatology.

The Use of Oral Antibiotics in the Management of Rosacea

J. D. Del Rosso, A. Nagler, 2019 .

Lidose-Isotretinoin Administered Without Food Improves Quality of Life in Patients With Severe Recalcitrant Nodular Acne: An Open-Label, Single-Arm, Phase IV Study.

C. Darby, A. Zaenglein, J. D. Del Rosso, 2020, The Journal of clinical and aesthetic dermatology.

Incorporation of a barrier protection cream in the management of chronic hand dermatitis: focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repair.

J. D. Del Rosso, 2014, ˜The œJournal of clinical and aesthetic dermatology.

An Aluminum Magnesium Hydroxide Stearate-based Skin Barrier Protection Cream Used for the Management of Eczematous Dermatitis: A Summary of Completed Studies.

J. D. Del Rosso, S. Bhambri, B. Michaels, 2008, The Journal of clinical and aesthetic dermatology.

Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant.

D. Thiboutot, Susun Bellew, J. D. Del Rosso, 2011, Journal of drugs in dermatology : JDD.

A status report on drug-associated acne and acneiform eruptions.

J. D. Del Rosso, Aaron Peterson, S. Momin, 2010, Journal of drugs in dermatology : JDD.

BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.

Z. Draelos, M. Gold, J. Fowler, 2018, The Journal of clinical and aesthetic dermatology.

Clinical significance of brand versus generic formulations: focus on oral minocycline.

J. D. Del Rosso, 2006, Cutis.

Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 1: overview, clinical characteristics, and laboratory evaluation.

E. Graber, D. Thiboutot, L. Eichenfield, 2015, Cutis.

Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris.

L. Kircik, J. D. Del Rosso, Conor J. Gallagher, 2015, The Journal of clinical and aesthetic dermatology.

Topical therapy for acne in women: is there a role for clindamycin phosphate-benzoyl peroxide gel?

J. D. Del Rosso, 2014, Cutis.

Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea.

A. Fleischer, D. Thiboutot, J. D. Del Rosso, 2008, Journal of drugs in dermatology : JDD.

Azelaic acid gel 15%: clinical versatility in the treatment of rosacea.

B. Elewski, A. Fleischer, Z. Draelos, 2006, Cutis.

Primary carcinosarcoma of the ear: case report and review of the literature.

Susun Bellew, J. D. Del Rosso, N. Mobini, 2009, ˜The œJournal of clinical and aesthetic dermatology.

Topical and oral antibiotics for acne vulgaris.

J. D. Del Rosso, 2016, Seminars in cutaneous medicine and surgery.

Consensus Recommendations on Adjunctive Topical Management of Atopic Dermatitis.

L. Kircik, D. Day, A. Hebert, 2018, Journal of drugs in dermatology : JDD.

Oral Apremilast for the Treatment of Plaque Psoriasis.

L. Kircik, J. D. Del Rosso, 2016, The Journal of clinical and aesthetic dermatology.

Emerging therapies in pediatric atopic dermatitis patients

B. Glick, Christopher M. Logas, J. D. Del Rosso, 2022, Dermatological Reviews.

New and emerging topical approaches for actinic keratoses.

J. D. Del Rosso, 2003, Cutis.

The use of topical imiquimod for the treatment of actinic keratosis: a status report.

J. D. Del Rosso, 2005, Cutis.

Avoiding the legal "blemish": medicolegal pitfalls in dermatology.

J. D. Del Rosso, S. Momin, B. Michaels, 2009, The Journal of clinical and aesthetic dermatology.

Betamethasone Valerate in Foam Vehicle is Effective with Both Daily and Twice a Day Dosing: A Single-Blind, Open-Label Study in the Treatment of Scalp Psoriasis

S. Feldman, A. Fleischer, J. Weiss, 2001 .

Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials

M. Lebwohl, Z. Draelos, M. Gooderham, 2021, SKIN The Journal of Cutaneous Medicine.

Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management.

J. D. Del Rosso, 2013, Journal of drugs in dermatology : JDD.

Atopic dermatitis and the stratum corneum: part 2: other structural and functional characteristics of the stratum corneum barrier in atopic skin.

S. Friedlander, J. D. Del Rosso, J. Levin, 2013, The Journal of clinical and aesthetic dermatology.

Imiquimod 2.5% and 3.75% Cream for the Treatment of Photodamage: A Meta-analysis of Efficacy and Tolerability in 969 Randomized Patients.

N. Swanson, B. Berman, T. Rosen, 2018, The Journal of clinical and aesthetic dermatology.

Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis

M. Lebwohl, L. Stein Gold, J. D. Del Rosso, 2021, The Journal of dermatological treatment.

Ingenol Mebutate Topical Gel A Status Report On Clinical Use Beyond Actinic Keratosis.

J. D. Del Rosso, 2016, The Journal of clinical and aesthetic dermatology.

Verruciform xanthoma of the glans penis: a benign clinical simulant of genital malignancy.

J. Murphy, J. D. Del Rosso, D. Geiss, 1993, Cutis.

The use of topical azelaic acid for common skin disorders other than inflammatory rosacea.

J. D. Del Rosso, 2006, Cutis.

Advancements in topical therapy

B. Glick, M. Ilyas, Christopher M. Logas, 2022, Dermatological Reviews.

Status Report on Topical Hypochlorous Acid: Clinical Relevance of Specific Formulations, Potential Modes of Action, and Study Outcomes.

J. D. Del Rosso, N. Bhatia, 2018, ˜The œJournal of clinical and aesthetic dermatology.

Anti-TNF agents for the treatment of psoriasis.

L. Kircik, J. D. Del Rosso, 2009, Journal of drugs in dermatology : JDD.

The Effect of Calcipotriene-Betamethasone Dipropionate Aerosol Foam versus Vehicle on Target Lesions in Moderate Severity Plaque Psoriasis: Focus on Elbows and Knees

L. Kircik, J. D. Del Rosso, 2019, Journal of drugs in dermatology : JDD.

The Personalized Acne Treatment Tool — Recommendations to facilitate a patient-centered approach to acne management from the Personalizing Acne: Consensus of Experts

B. Dréno, Jerry Tan, A. Layton, 2023, JAAD international.

Update from the Scientific Panel on Antibiotic Use in Dermatology: clinical considerations for the dermatologist.

J. D. Del Rosso, 2008, Cutis (New York, N.Y.).

A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.

D. Thiboutot, A. Shalita, L. Eichenfield, 2009, Cutis.

Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability.

J. D. Del Rosso, S. Bhambri, S. Momin, 2008, Cutis.

Clindamycin Phosphate 1.2%/Tretinoin 0.025% Gel for the Treatment of Acne Vulgaris: Which Patients are Most Likely to Benefit the Most?

J. D. Del Rosso, 2015, The Journal of clinical and aesthetic dermatology.

Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin.

J. Weiss, M. Rendon, E. Tanghetti, 2018, Journal of drugs in dermatology : JDD.

Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction.

J. D. Del Rosso, 2008, Journal of drugs in dermatology : JDD.

What's New in the Medicine Cabinet?: A Panoramic Review of Clinically Relevant Information for the Busy Dermatologist.

J. D. Del Rosso, J. Zeichner, 2014, The Journal of clinical and aesthetic dermatology.

Benzoyl peroxide cleansers for the treatment of acne vulgaris: status report on available data.

J. D. Del Rosso, 2008, Cutis.

Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea.

M. Rendon, G. Webster, M. Bradshaw, 2007, Journal of the American Academy of Dermatology.

Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris.

J. D. Del Rosso, 2007, Journal of drugs in dermatology : JDD.

Selection of therapy for acne vulgaris: balancing concerns about antibiotic resistance.

J. D. Del Rosso, 2008, Cutis.

Management of truncal acne vulgaris: current perspectives on treatment.

J. D. Del Rosso, 2006, Cutis.

A novel hydrogel vehicle formulated for the treatment of atopic dermatitis.

L. Kircik, J. D. Del Rosso, 2007, Journal of drugs in dermatology : JDD.

The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea.

J. Wolf, J. D. Del Rosso, 2007, Cutis.

A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.

J. Dover, Z. Draelos, M. Gold, 2013, Journal of Drugs in Dermatology.

The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.

D. Bucks, Karen Yu, J. D. Del Rosso, 2009, Journal of drugs in dermatology : JDD.

Introduction to atopic dermatitis

B. Glick, Christopher M. Logas, J. D. Del Rosso, 2021, Dermatological Reviews.

Cross-Sectional Survey of the Burden of Illness of Rosacea by Erythema Severity.

J. Harper, I. Ferrusi, J. D. Del Rosso, 2018, Journal of drugs in dermatology : JDD.

The impact of atopic dermatitis on the quality of life

B. Glick, Christopher M. Logas, J. D. Del Rosso, 2022, Dermatological Reviews.

Pathways to managing atopic dermatitis: consensus from the experts.

William Abramovits, M. Lebwohl, E. Guttman, 2013, The Journal of clinical and aesthetic dermatology.

Absence of Degradation of Tretinoin When Benzoyl Peroxide is Combined with an Optimized Formulation of Tretinoin Gel (0.05%).

J. D. Del Rosso, R. Pillai, Robert Moore, 2010, The Journal of clinical and aesthetic dermatology.

Recently approved systemic therapies for acne vulgaris and rosacea.

J. D. Del Rosso, 2007, Cutis.

The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection.

J. D. Del Rosso, 2013, ˜The œJournal of clinical and aesthetic dermatology.

Laser and light-based therapies for acne vulgaris: a current guide based on available data.

Grace K. Kim, J. D. Del Rosso, 2010, Journal of drugs in dermatology : JDD.

Calcipotriene-betamethasone dipropionate topical suspension in the management of psoriasis: a status report on available data with an overview of practical clinical application.

J. D. Del Rosso, 2014, Cutis.

Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris.

Avani Desai, J. D. Del Rosso, S. Bhambri, 2007, Cutis.

Overcoming the Barrier Treatment of Ichthyosis: A Combination-therapy Approach.

Susun Bellew, J. D. Del Rosso, 2010, The Journal of clinical and aesthetic dermatology.

Not all topical corticosteroids are created equal! Optimizing therapeutic outcomes through better understanding of vehicle formulations, compound selection,and methods of application.

L. Kircik, J. D. Del Rosso, 2012, Journal of drugs in dermatology : JDD.

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies.

D. Thiboutot, R. Gallo, L. Eichenfield, 2014, Cutis (New York, N.Y.).

Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.

M. Gooderham, Jerry Tan, D. Thiboutot, 2019, Journal of the American Academy of Dermatology.

Long‐term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified‐release capsules once daily

H. Baldwin, J. D. Del Rosso, Sam Brantman, 2021, Dermatologic therapy.

Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 4: a status report on physical modalities and devices.

D. Thiboutot, R. Gallo, L. Eichenfield, 2014, Cutis.

Topical antibiotics: therapeutic value or ecologic mischief?

Grace K. Kim, J. D. Del Rosso, 2009, Dermatologic therapy.

Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid.

L. Kircik, J. D. Del Rosso, 2014, Journal of drugs in dermatology : JDD.

The Growing Pains of Changing Times for Acne and Rosacea Pathophysiology: Where Will It All End Up?

J. D. Del Rosso, 2023, Cutis.

Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin.

S. Friedlander, J. D. Del Rosso, J. Levin, 2013, The Journal of clinical and aesthetic dermatology.

Retinoic acid receptors and topical acne therapy: establishing the link between gene expression and drug efficacy.

J. D. Del Rosso, 2002, Cutis.

The Importance of Medication Adherence in the Treatment of Actinic Keratosis: An Expert Consensus Panel

D. Rigel, J. D. Del Rosso, B. Berman, 2023, SKIN The Journal of Cutaneous Medicine.

Impact of Actinic Keratosis (AK), as measured by patient-reported AK symptoms, and impact on emotions and functioning (using Skindex-16) among patients with AK administered tirbanibulin in real-world community practices across the U.S. (PROAK Study)

D. Rigel, L. Kircik, I. Kasujee, 2023, SKIN The Journal of Cutaneous Medicine.

Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study)

D. Rigel, L. Kircik, I. Kasujee, 2023, SKIN The Journal of Cutaneous Medicine.

Erythropoietic protoporphyria: a case report and literature review.

J. D. Del Rosso, N. Mobini, B. Michaels, 2010, The Journal of clinical and aesthetic dermatology.